Researchers discover how to overcome a treatment resistance mechanism in one of the most aggressive types of breast cancer — ScienceDaily

The microenvironment surrounding tumors in HER2-positive breast cancer protects them and helps them develop resistance to the most widely used treatment, the monoclonal antibody trastuzumab. And a specific cell type in this microenvironment, fibroblasts, plays a key role in this process. These cells have the ability to block the immune system and thereby protect the …

Researchers discover how to overcome a treatment resistance mechanism in one of the most aggressive types of breast cancer — ScienceDaily Read More »